Jaguar Health advances MVID drug trial to extension phase

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. IBM
5. META
6. SPY
7. ACN
8. PRIM
9. PFE
10. TSLA

Go back to Jaguar Health advances MVID drug trial to extension phase
(NASDAQ: JAGX) Delayed: 2.55 -0.06 (2.3%)
Previous Close $2.61    52 Week High $4.60 
Open $2.50    52 Week Low $0.81 
Day High $2.64    P/E N/A 
Day Low $2.46    EPS $0.00 
Volume 86,753